Product Introduction
Dashori 100mg is a precision-targeted anticancer medication designed to inhibit tyrosine kinases, which are abnormal proteins involved in cancer progression. By effectively blocking these proteins, Dashori helps slow the growth of cancer cells and can induce remission in certain types of leukemia. Torrent Pharma ensures high-quality standards in manufacturing this advanced treatment option.
This medication represents a crucial advancement in the treatment of cancers driven by specific genetic mutations, providing patients with a better prognosis and quality of life when used under expert medical supervision.
Uses of Dashori 100mg
Dashori 100mg is primarily used for:
- Chronic Myeloid Leukemia (CML) – Effective for treating CML, particularly in newly diagnosed patients.
- Acute Lymphoblastic Leukemia (ALL) – Used for ALL cases that are Philadelphia chromosome-positive.
- Inhibition of Tyrosine Kinase Activity – Targets specific cancer-causing proteins to limit cell proliferation.
Dashori 100mg offers a reliable solution for managing these life-threatening cancers, supporting remission and improving patient outcomes.
Side Effects of Dashori 100mg
Common side effects of Dashori 100mg may include:
- Fatigue
- Diarrhea
- Nausea
- Swelling (edema)
- Low blood cell counts
Less Common Side Effects
Less frequent but potentially serious side effects include:
- Pulmonary arterial hypertension
- Liver enzyme abnormalities
- Severe infections
- Bleeding complications
We are pleased to offer you this product.
Dashori 100mg provides an effective approach to managing specific types of leukemia when used responsibly under the guidance of a healthcare provider. Its targeted action ensures optimal benefits with manageable side effects.
- Take as directed by your healthcare provider, usually once daily.
- Can be taken with or without food, but avoid grapefruit juice.
- Ensure regular follow-up visits for blood tests and health monitoring.
Dashori 100mg works by inhibiting BCR-ABL tyrosine kinase, an abnormal protein that drives the growth of cancer cells in Philadelphia chromosome-positive leukemia. By blocking this protein, Dashori helps slow down and stop the proliferation of cancerous cells.
- Targeted therapy with proven efficacy in CML and ALL.
- Helps achieve remission in Philadelphia chromosome-positive leukemia.
- Convenient once-daily dosing.
- Minimal drug interactions when used as prescribed.
- Regular blood tests are necessary to monitor health and efficacy.
- Avoid grapefruit and grapefruit juice as they can interact with the drug.
- Notify your doctor of any unusual symptoms, such as severe bleeding or difficulty breathing.